(1)
A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT). J of Skin 2022, 6 (6), s104. https://doi.org/10.25251/skin.6.supp.104.